Zobrazeno 1 - 10 of 52 pro vyhledávání: '"Gutiérrez-Chamorro L"'
2
Akademický článek
SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer.
Autor: Gutiérrez-Chamorro L; AIDS Research Institute-IrsiCaixa and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916, Badalona, Spain., Felip E; AIDS Research Institute-IrsiCaixa and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916, Badalona, Spain.; Medical Oncology Department, Catalan Institut of Oncology (ICO)-Badalona, B-ARGO (Badalona Applied Research Group in Oncology) and IGTP (Health Research Institute Germans Trias i Pujol), Universitat Autònoma de Barcelona, 08916, Badalona, Spain., Castellà E; Department of Pathology, Hospital Germans Trias i Pujol, IGTP (Health Research Institute Germans Trias I Pujol), Universitat Autònoma de Barcelona, 08916, Badalona, Spain., Quiroga V; Medical Oncology Department, Catalan Institut of Oncology (ICO)-Badalona, B-ARGO (Badalona Applied Research Group in Oncology) and IGTP (Health Research Institute Germans Trias i Pujol), Universitat Autònoma de Barcelona, 08916, Badalona, Spain., Ezeonwumelu IJ; AIDS Research Institute-IrsiCaixa and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916, Badalona, Spain., Angelats L; Medical Oncology Department, Catalan Institut of Oncology (ICO)-Badalona, B-ARGO (Badalona Applied Research Group in Oncology) and IGTP (Health Research Institute Germans Trias i Pujol), Universitat Autònoma de Barcelona, 08916, Badalona, Spain., Esteve A; Medical Oncology Department, Catalan Institut of Oncology (ICO)-Badalona, B-ARGO (Badalona Applied Research Group in Oncology) and IGTP (Health Research Institute Germans Trias i Pujol), Universitat Autònoma de Barcelona, 08916, Badalona, Spain., Perez-Roca L; Banc de Tumors, Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916, Badalona, Spain., Martínez-Cardús A; Medical Oncology Department, Catalan Institut of Oncology (ICO)-Badalona, B-ARGO (Badalona Applied Research Group in Oncology) and IGTP (Health Research Institute Germans Trias i Pujol), Universitat Autònoma de Barcelona, 08916, Badalona, Spain., Fernandez PL; Department of Pathology, Hospital Germans Trias i Pujol, IGTP (Health Research Institute Germans Trias I Pujol), Universitat Autònoma de Barcelona, 08916, Badalona, Spain., Ferrando-Díez A; Medical Oncology Department, Catalan Institut of Oncology (ICO)-Badalona, B-ARGO (Badalona Applied Research Group in Oncology) and IGTP (Health Research Institute Germans Trias i Pujol), Universitat Autònoma de Barcelona, 08916, Badalona, Spain., Pous A; Medical Oncology Department, Catalan Institut of Oncology (ICO)-Badalona, B-ARGO (Badalona Applied Research Group in Oncology) and IGTP (Health Research Institute Germans Trias i Pujol), Universitat Autònoma de Barcelona, 08916, Badalona, Spain., Bergamino M; Medical Oncology Department, Catalan Institut of Oncology (ICO)-Badalona, B-ARGO (Badalona Applied Research Group in Oncology) and IGTP (Health Research Institute Germans Trias i Pujol), Universitat Autònoma de Barcelona, 08916, Badalona, Spain., Cirauqui B; Medical Oncology Department, Catalan Institut of Oncology (ICO)-Badalona, B-ARGO (Badalona Applied Research Group in Oncology) and IGTP (Health Research Institute Germans Trias i Pujol), Universitat Autònoma de Barcelona, 08916, Badalona, Spain., Romeo M; Medical Oncology Department, Catalan Institut of Oncology (ICO)-Badalona, B-ARGO (Badalona Applied Research Group in Oncology) and IGTP (Health Research Institute Germans Trias i Pujol), Universitat Autònoma de Barcelona, 08916, Badalona, Spain., Teruel I; Medical Oncology Department, Catalan Institut of Oncology (ICO)-Badalona, B-ARGO (Badalona Applied Research Group in Oncology) and IGTP (Health Research Institute Germans Trias i Pujol), Universitat Autònoma de Barcelona, 08916, Badalona, Spain., Mesia R; Medical Oncology Department, Catalan Institut of Oncology (ICO)-Badalona, B-ARGO (Badalona Applied Research Group in Oncology) and IGTP (Health Research Institute Germans Trias i Pujol), Universitat Autònoma de Barcelona, 08916, Badalona, Spain., Clotet B; AIDS Research Institute-IrsiCaixa and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916, Badalona, Spain., Riveira-Muñoz E; AIDS Research Institute-IrsiCaixa and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916, Badalona, Spain., Margelí M; Medical Oncology Department, Catalan Institut of Oncology (ICO)-Badalona, B-ARGO (Badalona Applied Research Group in Oncology) and IGTP (Health Research Institute Germans Trias i Pujol), Universitat Autònoma de Barcelona, 08916, Badalona, Spain. mmargeli@iconcologia.net., Ballana E; AIDS Research Institute-IrsiCaixa and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916, Badalona, Spain. eballana@irsicaixa.es.
Publikováno v: Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2024 Feb; Vol. 47 (1), pp. 189-208. Date of Electronic Publication: 2023 Sep 04.
Zobrazit plný text záznamu
3
Akademický článek
Comparison of Reverse Transcription (RT)-Quantitative PCR and RT-Droplet Digital PCR for Detection of Genomic and Subgenomic SARS-CoV-2 RNA.
Autor: Morón-López S; IrsiCaixa AIDS Research Institute, Badalona, Spain.; CIBER de Enfermedades Infecciosas, Madrid, Spain., Riveira-Muñoz E; IrsiCaixa AIDS Research Institute, Badalona, Spain., Urrea V; IrsiCaixa AIDS Research Institute, Badalona, Spain., Gutiérrez-Chamorro L; IrsiCaixa AIDS Research Institute, Badalona, Spain., Ávila-Nieto C; IrsiCaixa AIDS Research Institute, Badalona, Spain., Noguera-Julian M; IrsiCaixa AIDS Research Institute, Badalona, Spain.; CIBER de Enfermedades Infecciosas, Madrid, Spain., Carrillo J; IrsiCaixa AIDS Research Institute, Badalona, Spain.; CIBER de Enfermedades Infecciosas, Madrid, Spain.; Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain., Mitjà O; Fight Infections Foundation, Badalona, Spain.; Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.; Lihir Medical Centre, International SOS, Londolovit, Lihir Island, Papua New Guinea., Mateu L; Fight Infections Foundation, Badalona, Spain.; Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.; Autonomous University of Barcelona (UAB), Barcelona, Spain., Massanella M; IrsiCaixa AIDS Research Institute, Badalona, Spain.; CIBER de Enfermedades Infecciosas, Madrid, Spain.; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain., Ballana E; IrsiCaixa AIDS Research Institute, Badalona, Spain.; Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain., Martinez-Picado J; IrsiCaixa AIDS Research Institute, Badalona, Spain.; CIBER de Enfermedades Infecciosas, Madrid, Spain.; Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.
Publikováno v: Microbiology spectrum [Microbiol Spectr] 2023 Mar 21, pp. e0415922. Date of Electronic Publication: 2023 Mar 21.
Zobrazit plný text záznamu
4
Akademický článek
SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis.
Autor: Gutiérrez-Chamorro L; IrsiCaixa AIDS Research Institute - and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., Felip E; IrsiCaixa AIDS Research Institute - and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.; Medical Oncology Department, Catalan Institute of Oncology (ICO), B-ARGO (Badalona Applied Research Group in Oncology), Health Research Institute Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona, Badalona, Spain., Bernat-Peguera A; Medical Oncology Department, Catalan Institute of Oncology (ICO), B-ARGO (Badalona Applied Research Group in Oncology), Health Research Institute Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona, Badalona, Spain., Ezeonwumelu IJ; IrsiCaixa AIDS Research Institute - and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., Teruel I; Medical Oncology Department, Catalan Institute of Oncology (ICO), B-ARGO (Badalona Applied Research Group in Oncology), Health Research Institute Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona, Badalona, Spain., Martínez-Cardús A; Medical Oncology Department, Catalan Institute of Oncology (ICO), B-ARGO (Badalona Applied Research Group in Oncology), Health Research Institute Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona, Badalona, Spain., Clotet B; IrsiCaixa AIDS Research Institute - and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.; Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Riveira-Muñoz E; IrsiCaixa AIDS Research Institute - and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., Romeo M; Medical Oncology Department, Catalan Institute of Oncology (ICO), B-ARGO (Badalona Applied Research Group in Oncology), Health Research Institute Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona, Badalona, Spain., Margelí M; Medical Oncology Department, Catalan Institute of Oncology (ICO), B-ARGO (Badalona Applied Research Group in Oncology), Health Research Institute Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona, Badalona, Spain., Ballana E; IrsiCaixa AIDS Research Institute - and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
Publikováno v: Frontiers in immunology [Front Immunol] 2023 Feb 09; Vol. 14, pp. 1112761. Date of Electronic Publication: 2023 Feb 09 (Print Publication: 2023).
Zobrazit plný text záznamu
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
Pharmacological Inhibition of IKK to Tackle Latency and Hyperinflammation in Chronic HIV-1 Infection.
Autor: Ezeonwumelu IJ; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Can Ruti Campus, 08916 Badalona, Spain., Garcia-Vidal E; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Can Ruti Campus, 08916 Badalona, Spain., Riveira-Muñoz E; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Can Ruti Campus, 08916 Badalona, Spain., Felip E; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Can Ruti Campus, 08916 Badalona, Spain.; Health Research Institute Germans Trias i Pujol (IGTP), Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain.; Medical Oncology Department, Catalan Institute of Oncology, Badalona-Applied Research Group in Oncology (B-ARGO), 08916 Badalona, Spain., Gutiérrez-Chamorro L; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Can Ruti Campus, 08916 Badalona, Spain., Calba I; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Can Ruti Campus, 08916 Badalona, Spain.; Health Research Institute Germans Trias i Pujol (IGTP), Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain., Massanella M; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Can Ruti Campus, 08916 Badalona, Spain.; University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), 28029 Madrid, Spain., Sirera G; Fight Infections Foundation, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain., Clotet B; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Can Ruti Campus, 08916 Badalona, Spain.; University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), 28029 Madrid, Spain., Ballana E; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Can Ruti Campus, 08916 Badalona, Spain.; Health Research Institute Germans Trias i Pujol (IGTP), Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain., Badia R; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Can Ruti Campus, 08916 Badalona, Spain.; Health Research Institute Germans Trias i Pujol (IGTP), Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain.
Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2022 Nov 30; Vol. 23 (23). Date of Electronic Publication: 2022 Nov 30.
Zobrazit plný text záznamu
7
Akademický článek
IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation.
Autor: Ezeonwumelu IJ; IrsiCaixa AIDS Research Institute - IrsiCaixa and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., García-Vidal E; IrsiCaixa AIDS Research Institute - IrsiCaixa and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., Felip E; IrsiCaixa AIDS Research Institute - IrsiCaixa and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Badalona, B-ARGO (Badalona Applied Research Group in Oncology) and IGTP (Health Research Institute Germans Trias i Pujol), Universitat Autònoma de Barcelona, Badalona, Spain., Puertas MC; IrsiCaixa AIDS Research Institute - IrsiCaixa and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.; Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Oriol-Tordera B; IrsiCaixa AIDS Research Institute - IrsiCaixa and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., Gutiérrez-Chamorro L; IrsiCaixa AIDS Research Institute - IrsiCaixa and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., Gohr A; Scientific Computing Facility, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany., Ruiz-Riol M; IrsiCaixa AIDS Research Institute - IrsiCaixa and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.; Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Massanella M; IrsiCaixa AIDS Research Institute - IrsiCaixa and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.; Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Clotet B; IrsiCaixa AIDS Research Institute - IrsiCaixa and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.; Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Centre for Health and Social Care Research (CESS), Faculty of Medicine, University of Vic - Central University of Catalonia (UVic - UCC), Vic, Spain., Martinez-Picado J; IrsiCaixa AIDS Research Institute - IrsiCaixa and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.; Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Centre for Health and Social Care Research (CESS), Faculty of Medicine, University of Vic - Central University of Catalonia (UVic - UCC), Vic, Spain.; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain., Badia R; IrsiCaixa AIDS Research Institute - IrsiCaixa and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., Riveira-Muñoz E; IrsiCaixa AIDS Research Institute - IrsiCaixa and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., Ballana E; IrsiCaixa AIDS Research Institute - IrsiCaixa and Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
Publikováno v: Frontiers in immunology [Front Immunol] 2022 Sep 05; Vol. 13, pp. 1001068. Date of Electronic Publication: 2022 Sep 05 (Print Publication: 2022).
Zobrazit plný text záznamu
8
Akademický článek
Modulation of DNA Damage Response by SAM and HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) Determines Prognosis and Treatment Efficacy in Different Solid Tumor Types.
Autor: Felip E; AIDS Research Institute-IrsiCaixa, IGTP (Health Research Institute Germans Trias i Pujol), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain.; Medical Oncology Department, Catalan Institute of Oncology-Badalona, Hospital Germans Trias i Pujol (HGTiP), 08916 Badalona, Spain.; (B-ARGO) Badalona Applied Research Group in Oncology, (IGTP), Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Departament de Medicina, Universitat Autònoma de Barcelona, 08916 Badalona, Spain., Gutiérrez-Chamorro L; AIDS Research Institute-IrsiCaixa, IGTP (Health Research Institute Germans Trias i Pujol), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain., Gómez M; Department of Pathology, IGTP (Health Research Institute Germans Trias i Pujol), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain., Garcia-Vidal E; AIDS Research Institute-IrsiCaixa, IGTP (Health Research Institute Germans Trias i Pujol), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain., Romeo M; Medical Oncology Department, Catalan Institute of Oncology-Badalona, Hospital Germans Trias i Pujol (HGTiP), 08916 Badalona, Spain.; (B-ARGO) Badalona Applied Research Group in Oncology, (IGTP), Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Departament de Medicina, Universitat Autònoma de Barcelona, 08916 Badalona, Spain., Morán T; Medical Oncology Department, Catalan Institute of Oncology-Badalona, Hospital Germans Trias i Pujol (HGTiP), 08916 Badalona, Spain.; (B-ARGO) Badalona Applied Research Group in Oncology, (IGTP), Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Departament de Medicina, Universitat Autònoma de Barcelona, 08916 Badalona, Spain., Layos L; Medical Oncology Department, Catalan Institute of Oncology-Badalona, Hospital Germans Trias i Pujol (HGTiP), 08916 Badalona, Spain.; (B-ARGO) Badalona Applied Research Group in Oncology, (IGTP), Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Departament de Medicina, Universitat Autònoma de Barcelona, 08916 Badalona, Spain., Pérez-Roca L; Banc de Tumors, IGTP (Health Research Institute Germans Trias i Pujol), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain., Riveira-Muñoz E; AIDS Research Institute-IrsiCaixa, IGTP (Health Research Institute Germans Trias i Pujol), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain., Clotet B; AIDS Research Institute-IrsiCaixa, IGTP (Health Research Institute Germans Trias i Pujol), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain., Fernandez PL; Department of Pathology, IGTP (Health Research Institute Germans Trias i Pujol), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain., Mesía R; Medical Oncology Department, Catalan Institute of Oncology-Badalona, Hospital Germans Trias i Pujol (HGTiP), 08916 Badalona, Spain.; (B-ARGO) Badalona Applied Research Group in Oncology, (IGTP), Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Departament de Medicina, Universitat Autònoma de Barcelona, 08916 Badalona, Spain., Martínez-Cardús A; Medical Oncology Department, Catalan Institute of Oncology-Badalona, Hospital Germans Trias i Pujol (HGTiP), 08916 Badalona, Spain.; (B-ARGO) Badalona Applied Research Group in Oncology, (IGTP), Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Departament de Medicina, Universitat Autònoma de Barcelona, 08916 Badalona, Spain., Ballana E; AIDS Research Institute-IrsiCaixa, IGTP (Health Research Institute Germans Trias i Pujol), Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, Spain., Margelí M; Medical Oncology Department, Catalan Institute of Oncology-Badalona, Hospital Germans Trias i Pujol (HGTiP), 08916 Badalona, Spain.; (B-ARGO) Badalona Applied Research Group in Oncology, (IGTP), Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Departament de Medicina, Universitat Autònoma de Barcelona, 08916 Badalona, Spain.
Publikováno v: Cancers [Cancers (Basel)] 2022 Jan 27; Vol. 14 (3). Date of Electronic Publication: 2022 Jan 27.
Zobrazit plný text záznamu
9
Akademický článek
SARS-CoV-2 Infection Modulates ACE2 Function and Subsequent Inflammatory Responses in Swabs and Plasma of COVID-19 Patients.
Autor: Gutiérrez-Chamorro L; IrsiCaixa-AIDS Research Institute, Health Research Institute Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona, 08916 Badalona, Spain., Riveira-Muñoz E; IrsiCaixa-AIDS Research Institute, Health Research Institute Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona, 08916 Badalona, Spain., Barrios C; Hospital del Mar Department of Nephrology, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain., Palau V; Hospital del Mar Department of Nephrology, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain., Nevot M; IrsiCaixa-AIDS Research Institute, Health Research Institute Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona, 08916 Badalona, Spain., Pedreño-López S; IrsiCaixa-AIDS Research Institute, Health Research Institute Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona, 08916 Badalona, Spain., Senserrich J; IrsiCaixa-AIDS Research Institute, Health Research Institute Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona, 08916 Badalona, Spain., Massanella M; IrsiCaixa-AIDS Research Institute, Health Research Institute Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona, 08916 Badalona, Spain., Clotet B; IrsiCaixa-AIDS Research Institute, Health Research Institute Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona, 08916 Badalona, Spain.; Fight AIDS and Infectious Diseases Foundation, 08916 Badalona, Spain.; Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.; Universitat Central de Catalunya, Universitat de Vic, 08500 Vic, Spain., Cabrera C; IrsiCaixa-AIDS Research Institute, Health Research Institute Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona, 08916 Badalona, Spain., Mitjà O; Fight AIDS and Infectious Diseases Foundation, 08916 Badalona, Spain.; Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.; Universitat Central de Catalunya, Universitat de Vic, 08500 Vic, Spain.; Lihir Medical Centre-International SOS, Londolovit, Lihir Island, Papua New Guinea., Crespo M; Hospital del Mar Department of Nephrology, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain., Pascual J; Hospital del Mar Department of Nephrology, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain., Riera M; Hospital del Mar Department of Nephrology, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain., Ballana E; IrsiCaixa-AIDS Research Institute, Health Research Institute Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona, 08916 Badalona, Spain.
Publikováno v: Viruses [Viruses] 2021 Aug 28; Vol. 13 (9). Date of Electronic Publication: 2021 Aug 28.
Zobrazit plný text záznamu
10
Akademický článek
Deciphering the role of SAMHD1 in endometrial cancer progression.
Autor: Qiang, Ping1 (AUTHOR), Chen, Ying2 (AUTHOR), Shao, Yang1 (AUTHOR), Deng, Qicheng2 (AUTHOR), Xu, Songyuan1 (AUTHOR), Zhu, Weipei2 (AUTHOR) zwp3333@suda.edu.cn
Publikováno v: Biology Direct. 10/11/2024, Vol. 19 Issue 1, p1-15. 15p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje